Advertisement
Screener

Fusion Pharmaceuticals Inc. Increase (Decrease) in Accounts Payable

Fusion Pharmaceuticals Inc. Increase (Decrease) in Accounts Payable

Fusion Pharmaceuticals Inc. reported Increase (Decrease) in Accounts Payable of $445.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2024-05-07

  • Fusion Pharmaceuticals Inc. increase (decrease) in accounts payable for the quarter ending 2024-03-31 was $445.00K.
  • Fusion Pharmaceuticals Inc. increase (decrease) in accounts payable for the quarter ending 2023-12-31 was $821.00K, a 36.16% decline year-over-year.
  • Fusion Pharmaceuticals Inc. increase (decrease) in accounts payable for the quarter ending 2023-09-30 was -$998.00K.
  • Fusion Pharmaceuticals Inc. increase (decrease) in accounts payable for the quarter ending 2023-06-30 was $160.00K.
  • Fusion Pharmaceuticals Inc. increase (decrease) in accounts payable for fiscal 2023 was -$721.00K, a 280.25% decline from fiscal 2022.
  • Fusion Pharmaceuticals Inc. increase (decrease) in accounts payable for fiscal 2022 was $400.00K.
  • Fusion Pharmaceuticals Inc. increase (decrease) in accounts payable for fiscal 2021 was -$1.18M, a 146.25% decline from fiscal 2020.
  • Fusion Pharmaceuticals Inc. increase (decrease) in accounts payable for fiscal 2020 was $2.56M, a 434.03% increase from fiscal 2019.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 12 month
2024-03-31$445.00K
10-Q · filed 2024-05-07
$1.27M
derived: sum of 2 quarters · filed 2024-05-07
$268.00K
derived: sum of 3 quarters · filed 2024-05-07
$428.00K
derived: sum of 4 quarters · filed 2024-05-07
2023-12-31$821.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
-$177.00K
derived: sum of 2 quarters · filed 2024-03-20
-$17.00K
derived: sum of 3 quarters · filed 2024-03-20
-$721.00K
10-K · filed 2024-03-20
2023-09-30-$998.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$838.00K
derived: sum of 2 quarters · filed 2023-11-07
-$1.54M
10-Q · filed 2023-11-07
-$256.00K
derived: sum of 4 quarters · filed 2024-05-07
2023-06-30$160.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$544.00K
10-Q · filed 2023-08-08
$742.00K
derived: sum of 3 quarters · filed 2024-05-07
$493.00K
derived: sum of 4 quarters · filed 2024-05-07
2023-03-31-$704.00K
10-Q · filed 2024-05-07
$582.00K
derived: sum of 2 quarters · filed 2024-05-07
$333.00K
derived: sum of 3 quarters · filed 2024-05-07
$259.00K
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31$1.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
$1.04M
derived: sum of 2 quarters · filed 2024-03-20
$963.00K
derived: sum of 3 quarters · filed 2024-03-20
$400.00K
10-K · filed 2024-03-20
2022-09-30-$249.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$323.00K
derived: sum of 2 quarters · filed 2023-11-07
-$886.00K
10-Q · filed 2023-11-07
-$2.48M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$74.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$637.00K
10-Q · filed 2023-08-08
-$2.23M
derived: sum of 3 quarters · filed 2023-08-08
$867.00K
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$563.00K
10-Q · filed 2023-05-11
-$2.16M
derived: sum of 2 quarters · filed 2023-05-11
$941.00K
derived: sum of 3 quarters · filed 2023-05-11
$600.00K
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$1.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$1.50M
derived: sum of 2 quarters · filed 2023-03-16
$1.16M
derived: sum of 3 quarters · filed 2023-03-16
-$1.18M
10-K · filed 2023-03-16
2021-09-30$3.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$2.76M
derived: sum of 2 quarters · filed 2022-11-08
$413.00K
10-Q · filed 2022-11-08
$2.82M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30-$341.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$2.69M
10-Q · filed 2022-08-09
-$279.00K
derived: sum of 3 quarters · filed 2022-08-09
$190.00K
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31-$2.35M
10-Q · filed 2022-05-10
$62.00K
derived: sum of 2 quarters · filed 2022-05-10
$531.00K
derived: sum of 3 quarters · filed 2022-05-10
-$646.00K
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$2.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
$2.88M
derived: sum of 2 quarters · filed 2022-03-17
$1.70M
derived: sum of 3 quarters · filed 2022-03-17
$2.56M
10-K · filed 2022-03-17
2020-09-30$469.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$708.00K
derived: sum of 2 quarters · filed 2021-11-09
$150.00K
10-Q · filed 2021-11-09
$221.00K
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$1.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
-$319.00K
10-Q · filed 2021-08-10
-$248.00K
derived: sum of 3 quarters · filed 2021-08-10
$172.00K
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31$858.00K
10-Q · filed 2021-05-11
$929.00K
derived: sum of 2 quarters · filed 2021-05-11
$1.35M
derived: sum of 3 quarters · filed 2021-05-11
2019-12-31$71.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
$491.00K
derived: sum of 2 quarters · filed 2021-03-25
$479.00K
10-K · filed 2021-03-25
2019-09-30$420.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
$408.00K
10-Q · filed 2020-11-10
2019-06-30-$12.00K
10-Q · filed 2020-08-11